Seroepidemiology of Rubella in Mozambique, 2006-2014: Implications for Rubella Immunization in Settings With High

Nádia Alves Amade1, Thebora Sultane, Orvalho Augusto

  • 1From the *Department of Technological Platforms, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique; and †Faculdade de Medicina, Eduardo Mondlane University, Maputo, Mozambique.

Abstract

Insights

Rubella is common in Mozambique, especially among women of childbearing age. This highlights the need for rubella vaccination campaigns targeting children and adolescents to prevent congenital rubella syndrome.

Area of Science:

  • Epidemiology
  • Immunology
  • Public Health

Background:

  • Rubella and congenital rubella syndrome are underreported in sub-Saharan Africa.
  • Vaccination against rubella is not yet standard in national immunization schedules in many of these countries.

Purpose of the Study:

  • To investigate the frequency of immunoglobulin M antibodies against rubella in Mozambique.
  • To examine correlations between rubella seroprevalence and fertility rates from 2006 to 2014.

Main Methods:

  • Retrospective analysis of data from Mozambique's routine measles surveillance system.
  • Testing of 7312 serum samples from suspected measles cases for rubella immunoglobulin M antibodies between 2006 and 2014.

Main Results:

  • 18.2% of samples tested positive for rubella immunoglobulin M antibodies.
  • The highest rubella frequency was observed in the 5-9-year-old age group (32.6%).
  • Rubella was also frequent in women of childbearing age (15-29 years).

Conclusions:

  • Rubella is prevalent among women of childbearing age in Mozambique.
  • The high frequency suggests a risk of congenital rubella syndrome due to early pregnancies.
  • Routine rubella vaccination for children, alongside campaigns for older individuals, is recommended.